Phase I Study of N1-N11-Diethylnorspermine (DENSPM) Administered TID for 6 Days in Patients with Advanced Malignancies
Richard R. Streiff, John F. BenderVolume:
19
Language:
english
Pages:
11
DOI:
10.1023/a:1006448516938
Date:
February, 2001
File:
PDF, 84 KB
english, 2001